Home▸Articles▸Prostate Cancer Treatment

Androgen Deprivation Therapy (Leuprolide) Explained

Understanding how leuprolide works to suppress testosterone production in the treatment of prostate cancer.

mysimulator teamUpdated June 2026≈ 4 min read▶ Open the simulation

What is Androgen Deprivation Therapy (Leuprolide)?

Androgen deprivation therapy (ADT) is a common treatment for prostate cancer that involves reducing the levels of androgens, particularly testosterone. Leuprolide, an LHRH agonist, is one such medication used in ADT. It works by binding to luteinizing hormone-releasing hormone (LHRH) receptors on the pituitary gland, leading to a decrease in the production of luteinizing hormone (LH), which in turn reduces testosterone levels.

The therapy typically involves an initial surge in testosterone levels as the body's natural hormonal balance is disrupted. This is followed by a sustained suppression of testosterone production, effectively castrating the patient and slowing down or stopping tumor growth.

Mechanisms Behind Leuprolide’s Action

Leuprolide acts on the hypothalamic-pituitary-gonadal axis. It mimics the natural LHRH, but with a much longer duration of action and higher affinity for its receptors. This prolonged stimulation leads to a desensitization of the pituitary gland, reducing its ability to produce LH. As a result, the Leydig cells in the testes are no longer stimulated to produce testosterone.

The initial surge in testosterone levels is due to the body's attempt to compensate for the sudden decrease in LH, which triggers an acute release of stored testosterone from the Leydig cells before their function is permanently inhibited.

live demo · related simulation● LIVE

Why Does Androgen Deprivation Therapy Matter?

Androgen deprivation therapy is crucial in managing prostate cancer because it can significantly reduce tumor growth and improve survival rates. By lowering testosterone levels, the therapy helps to shrink tumors, relieve symptoms such as bone pain, and prevent metastasis.

Moreover, ADT can be used both as a primary treatment for early-stage prostate cancer and as an adjunctive therapy in advanced stages or when other treatments have failed.

Real-World Applications of Leuprolide

Leuprolide is widely used in clinical practice, particularly in the treatment of metastatic prostate cancer. It can also be employed for non-cancerous conditions such as benign prostatic hyperplasia (BPH) and in fertility treatments to suppress testosterone levels.

The therapy's effectiveness has been demonstrated in numerous studies, highlighting its importance in managing various male health issues.

Frequently asked questions

How does leuprolide cause the initial surge in testosterone levels?

Leuprolide initially causes a surge in testosterone because it mimics LHRH, triggering an acute release of stored testosterone from the Leydig cells before their function is permanently inhibited.

Is androgen deprivation therapy effective for all types of prostate cancer?

Androgen deprivation therapy can be highly effective for hormone-sensitive prostate cancers but may not work as well for metastatic castration-resistant prostate cancer, where other treatments might be necessary.

What are the side effects of leuprolide treatment?

Side effects can include hot flashes, decreased libido, erectile dysfunction, and mood changes. These effects are generally manageable with appropriate medical support.

Can leuprolide be used for other conditions besides prostate cancer?

Yes, leuprolide is also used in the treatment of non-cancerous conditions like BPH and in fertility treatments to suppress testosterone levels.

Try it live

Everything above runs in your browser — open Androgen Deprivation Therapy (Leuprolide) Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Androgen Deprivation Therapy (Leuprolide) Simulator simulation

What did you find?

Add reproduction steps (optional)